Monday, 28 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Earnings Call

Acutaas Chemicals Earnings Call: Key Takeaways

Acutaas Chemicals delivered record FY26 results with Revenue of ₹13,394 Mn and PAT of ₹3,564 Mn, driven by expansion in pharmaceutical and semiconductor segments.

Why this was an Alfa AlertNot a filter event. While performance is record-breaking, it was not explicitly stated as beating specific prior management guidance.
Highlights
Revenue growth33% YoY growth to ₹13,394 Mn in FY26.
MarginsEBITDA margins reached a record 35.9% in FY26.
Demand visibilityStrong; expanding into high-purity semiconductor and battery chemicals markets.
Management confidenceStrong confidence reflected in ₹1000+ Cr capex plan through FY30.

Growth

Total revenue grew 33% YoY in FY26; EBITDA margin expanded significantly to 35.9% from 23% in FY25.

Outlook

Investing ₹1000+ Cr (FY23-30) across Pharma, Battery, and Semiconductor sectors; South Korea facility under construction.

Risks

Exposure to global market overcapacity in commodity chemicals and high R&D intensity requirements.

Source

Earnings Call filed with NSE, NSE: ACUTAAS. Summary written with AI assistance from the document.

Read the document ↗

Acutaas Chemicals Ltd: key numbers

Share price
₹3,272.50
Market cap
₹26,792 Cr
Revenue (annual)
₹1,339 Cr
Net profit (annual)
₹356.3 Cr
P/E (TTM)
69.4×Sector 50.4×
Promoter holding
32.66%+0.00% QoQ
FII holding
21.61%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Acutaas Chemicals Ltd

All →
19:20 IST BSE
Management Change

Acutaas Chemicals Management Change

Acutaas Chemicals Limited has announced the re-appointment of Ram Mohan Lokhande as Executive Director and Anita Bandyopadhyay as Non-Executive Independent Director for a 60-month term.

20:03 IST BSE
Acquisition

Acutaas Chemicals Acquisition Worth ₹0.01 Cr

Acutaas Chemicals will acquire 100% of Enchem Ami Organics Private Limited for Rs. 1 Lakh, making it a wholly owned subsidiary.

Value
₹0.01 Cr
Execution
One month
19:36 IST BSE
Merger & Restructuring

Acutaas Chemicals Merger & Restructuring Worth ₹0.01 Cr

Acutaas Chemicals will acquire 100% equity stake in step-down subsidiary Enchem Ami Organics for Rs. 1 Lakh, making it a direct wholly-owned subsidiary.

Value
₹0.01 Cr
Execution
within one month
17:22 IST BSE
Annual General Meeting

Acutaas Chemicals Annual General Meeting

Acutaas Chemicals Limited conducted its 19th Annual General Meeting on September 24, 2026, where shareholders transacted various ordinary and special business items.

17:59 IST BSE
Patent

Acutaas Chemicals Patent

Acutaas Chemicals Limited has received a patent from the Indian Patent Office for a process to prepare 2,4-dimethylthiophenol. The company now holds 11 patents.

12:04 IST BSE
Capacity Expansion

Acutaas Chemicals Capacity Expansion

Acutaas Chemicals Limited inaugurated a new state-of-the-art Pilot Plant at Unit 1 in Sachin, Surat. The facility supports R&D for high potency active pharmaceutical ingredients.

pilot plant
1.0 plants